Oklahoma · 2025 Regular Session · Bill
HB 2801: Antipsychotic drugs; vendor drug program; Oklahoma Health Care Authority; prior authorized; disorders; prior authorization; effective date.
Passed one chamber Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 2801 is a bill introduced in the Oklahoma House on February 3, 2025. According to its official title, it concerns: Antipsychotic drugs; vendor drug program; Oklahoma Health Care Authority; prior authorized; disorders; prior authorization; effective date. Primary sponsor: Brenda Stanley (Republican), T.J. Marti (Republican). Most recent recorded action (April 1, 2025): Second Reading referred to Health and Human Services Committee then to Appropriations Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Brenda Stanley | Primary sponsor | Republican | Senate | 42 |
| T.J. Marti | Primary sponsor | Republican | House | 75 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Second Reading referred to Health and Human Services Committee then to Appropriations Committee
- First Reading
- Engrossed, signed, to Senate
- Referred for engrossment
- Third Reading, Measure passed: Ayes: 87 Nays: 0
- Title stricken
- Amended
- General Order
- CR; Do Pass Health and Human Services Oversight Committee
- Authored by Senator Stanley (principal Senate author)
- Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health
- Referred to Public Health
Showing 12 most recent of 15 actions. Full history